August 04, 2022
The principal investigator of the HOPE-2 trial discussed safety and efficacy of Capricor’s CAP-1002.
July 21, 2022
The principal investigator of the HOPE-2 trial discussed results of the trial in the non-ambulatory population of patients with Duchenne muscular dystrophy.